Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
Cell Reports
|
October 21, 2016
Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants
Lisa Brenan, Aleksandr Andreev, Ofir Cohen, et al.
Military Medical Research
|
November 25, 2021
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019
Hao Zi, Shao-Hua He, Xie-Yuan Leng, et al.
Military Medical Research
|
May 19, 2024
P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway
Shuang-Ying Wang, Yi Cai, Xiao Hu, et al.
Nature
|
December 10, 2020
A metastasis map of human cancer cell lines
Xin Jin, Zelalem Demere, Karthik Nair, et al.
Genome Research
|
January 23, 2009
High-resolution DNA-binding specificity analysis of yeast transcription factors
Cong Zhu, Kelsey J R P Byers, Rachel Patton McCord, et al.
Journal of Neuromuscular Diseases
|
July 12, 2024
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
Eduardo Arteaga-Bracho, Gautier Cosne, Christoph Kanzler, et al.
Genome Research
|
March 9, 2013
Global analysis of Drosophila Cys₂-His₂ zinc finger proteins reveals a multitude of novel recognition motifs and binding determinants
Metewo Selase Enuameh, Yuna Asriyan, Adam Richards, et al.
Neuro-Oncology
|
August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Radhe Mohan, Amy Y Liu, Paul D Brown, et al.
Military Medical Research
|
May 29, 2025
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
Cong Zhu, Lu-Yao Li, Ming-Hui Shi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1
Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
Cell Reports
|
October 21, 2016
Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants
Lisa Brenan, Aleksandr Andreev, Ofir Cohen, et al.
Military Medical Research
|
November 25, 2021
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019
Hao Zi, Shao-Hua He, Xie-Yuan Leng, et al.
Military Medical Research
|
May 19, 2024
P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway
Shuang-Ying Wang, Yi Cai, Xiao Hu, et al.
Nature
|
December 10, 2020
A metastasis map of human cancer cell lines
Xin Jin, Zelalem Demere, Karthik Nair, et al.
Genome Research
|
January 23, 2009
High-resolution DNA-binding specificity analysis of yeast transcription factors
Cong Zhu, Kelsey J R P Byers, Rachel Patton McCord, et al.
Journal of Neuromuscular Diseases
|
July 12, 2024
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
Eduardo Arteaga-Bracho, Gautier Cosne, Christoph Kanzler, et al.
Genome Research
|
March 9, 2013
Global analysis of Drosophila Cys₂-His₂ zinc finger proteins reveals a multitude of novel recognition motifs and binding determinants
Metewo Selase Enuameh, Yuna Asriyan, Adam Richards, et al.
Neuro-Oncology
|
August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Radhe Mohan, Amy Y Liu, Paul D Brown, et al.
Military Medical Research
|
May 29, 2025
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
Cong Zhu, Lu-Yao Li, Ming-Hui Shi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2025
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1
Saadettin Kilickap, Ana Baramidze, Ahmet Sezer, et al.
Page
of 15